- Research article
- Open Access
- Open Peer Review
Vaginal innate immune mediators are modulated by a water extract of Houttuynia cordata Thunb
BMC Complementary and Alternative Medicinevolume 15, Article number: 183 (2015)
Vaginal epithelial cells (VECs) produce antimicrobial peptides including human β-defensin 2 (hBD2) and secretory leukocyte protease inhibitor (SLPI), as well as cytokines and chemokines that play vital roles in mucosal innate immunity of the female reproductive tract. Houttuynia cordata Thunb (H. cordata), a herbal plant found in Asia, possesses various activities including antimicrobial activity and anti-inflammation. As inflammation and infection are commonly found in female reproductive tract, we aimed to investigate the effects of H. cordata water extract in modulating innate immune factors produced by VECs.
Primary human VECs were cultured and treated with H. cordata at a concentration ranging from 25–200 μg/ml for 6 or 18 h. After treatment, the cells and culture supernatants were harvested. The expression of hBD2 and SLPI mRNA was evaluated by quantitative real-time reverse transcription PCR. Levels of secreted hBD2 and SLPI as well as cytokines and chemokines in the supernatants were measured by ELISA and Luminex assay, respectively. Cytotoxicity of the extract on VECs was assessed by CellTiter-Blue Cell Viability Assay.
H. cordata did not cause measurable toxicity on VECs after exposure for 18 h. The expression of hBD2 and SLPI mRNA as well as the secreted hBD2 protein were increased in response to H. cordata exposure for 18 h when compared to the untreated controls. However, treatment with the extract for 6 h had only slight effects on the mRNA expression of hBD2 and SLPI. The secretion of IL-2 and IL-6 proteins by VECs was also increased, while the secretion of CCL5 was decreased after treatment with the extract for 18 h. Treatment with H. cordata extract had some effects on the secretion of IL-4, IL-8, CCL2, and TNF-α, but not statistically significant.
H. cordata water extract modulates the expression of antimicrobial peptides and cytokines produced by VECs, which play an important role in the mucosal innate immunity in the female reproductive tract. Our findings suggest that H. cordata may have immunomodulatory effects on the vaginal mucosa. Further studies should be performed in vivo to determine if it can enhance mucosal immune defenses against microbial pathogens.
The lower female reproductive tract is the site of entry for several pathogens including bacteria, yeasts, and viruses that may cause sexually transmitted infections [1, 2]. The immune system of mucosal surfaces functions as the first line of host defense against pathogen invasion to protect underlying tissues and organs [1, 3]. The vaginal epithelium plays an important role in the innate immunity of the female reproductive tract, by providing a physical barrier and producing antimicrobial peptides, such as human β-defensin 2 (hBD2) and secretory leukocyte protease inhibitor (SLPI), and other innate immune mediators, in particular cytokines and chemokines [2, 4–6]. These immune mediators possess potent antimicrobial activities against a broad range of infectious pathogens, including human immunodeficiency virus type 1 (HIV-1) and Candida albicans, and play significant roles in host immune responses and homeostasis [7–14].
Previous studies revealed that hBD2 and SLPI can inhibit HIV-1 infection [7, 10, 15, 16]. However, the secretion of hBD2 and SLPI in cervicovaginal lavages may fluctuate during a menstrual cycle . In addition, levels of SLPI protein have been shown to be decreased in the cervicovaginal secretions of post-menopausal women . These may lead to impairment of the immune responses and make those women become susceptible to immune-mediated vaginal infections. Thus, the induction of these immune mediators may help in maintaining mucosal immunity and preventing microbial invasion.
Some of these immune mediators are constitutively produced by vaginal epithelial cells (VECs). They can also be up-regulated by different microbial components and cytokines [4, 5, 18]. Previous studies reported that the production of hBD2 and SLPI by epithelial cells was induced by various microbes, microbial compounds, and cytokines [18–22]. Moreover, levels of cytokine and chemokine production were increased in response to different microorganisms and other cytokines [4, 5, 12, 18]. It is not known, however, if the expression of these innate immune mediators can be up-regulated by herbal plant extracts.
Houttuynia cordata Thunb (H. cordata), a herbal plant found in Asian countries, has long been in medical and dietary use by local people in this region . It has antimicrobial activity against several bacteria and viruses [23–26], and also possesses other activities including anti-allergic , anti-inflammatory , antioxidative , and anticancer effects [30, 31]. Most laboratory studies have focused on the modulation of antimicrobial peptides and innate immune mediators by microbial components [18–21], but the role of herbal plant extracts on mucosal innate immunity is not well established. Therefore, the goal of this study was to evaluate the effects of H. cordata extract on the expression of hBD2 and SLPI as well as various cytokines and chemokines produced by human VECs. We demonstrated that H. cordata water extract induced the expression of hBD2 and SLPI mRNA in human VEC culture without measurable cytotoxicity. The secretion of hBD2 protein and the levels of IL-2 and IL-6 in the cell culture supernatants were also significantly increased in the presence of the extract.
Compound and reagent
Pure powdered extract of H. cordata was ordered from Erica Botanical Products (Xi’an, China). It was certified as free of bacterial or fungal contamination. The stock solution was prepared in sterile water. Tumor necrosis factor-alpha (TNF-α) used as a positive control for the induction of hBD2 and SLPI was ordered from PeproTech (Rocky Hill, CT, USA).
Fibroblast cell culture
The fibroblast 3T3-J2 cells were kindly provided by Cary A. Moody from the Department of Microbiology and Immunology, University of North Carolina-Chapel Hill. The cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Life Technologies, Grand Island, NY, USA) with 10 % heat inactivated fetal bovine serum, L-glutamine, and penicillin-streptomycin at 37 °C in a humidified atmosphere containing 5 % CO2. For use as feeders for the vaginal epithelial cells, the fibroblasts were grown to 70–80 % confluence and irradiated with 6000 Rads.
Primary human vaginal epithelial cell isolation and culture
Tissues routinely discarded from vaginal repair surgeries were harvested from three otherwise healthy adult women, with the understanding and written consent of each subject and according to ethical principles. Tissue harvesting and experimental procedures were approved by the Institutional Review Boards of the University of Washington and the Fred Hutchinson Cancer Research Center. Tissues were placed in ice-cooled calcium- and magnesium-free phosphate-buffered saline containing 100 U/ml penicillin, 100 μg/ml streptomycin and 2.5 μg/ml Fungizone (Life Technologies), and transported to the laboratory within 1 h of removal from the donor. The deep submucosa was removed with surgical scissors and the remaining vaginal mucosa was cut into 5 × 5 mm pieces, which were incubated at 4 °C for 18 h in 5 ml of a 25 U/ml dispase solution (BD Biosciences, Franklin Lakes, NJ, USA). The epithelial sheets were dissected off under a stereoscope and incubated for 10–12 min at 37 °C in 2 ml 0.05 % trypsin while gently shaking. The dispersed cells were poured through a 100 μm cell strainer into a 50 ml tube, pelleted by centrifugation, and resuspended in F medium (3:1 [v/v] F12 [Ham]-DMEM [Life Technologies], 5 % fetal bovine serum [Gemini Bio-Products, West Sacramento, CA, USA], 0.4 μg/ml hydrocortisone [Sigma, St. Louis, MO, USA], 5 μg/ml insulin [Gemini Bio-Products], 8.4 ng/ml cholera toxin [EMD Millipore, Billerica, MA, USA], 10 ng/ml epidermal growth factor [Life Technologies], 24 μg/ml adenine [Sigma], 100 U/ml penicillin, 100 μg/ml streptomycin [Life Technologies], and 2 mM glutamine [Life Technologies]). Primary VECs were plated into culture flasks in the presence of ~12,500/cm2 irradiated (6000 Rads) 3T3-J2 feeder fibroblasts and 10 μM of Rho kinase inhibitor Y27632 (Enzo Life Sciences, Farmingdale, NY, USA) was added [32, 33]. VECs were fed every 2–3 days and passaged when around 80 % confluence by 1 min treatment with 10 ml versene (Life Technologies) to remove the feeder cells, followed by 5 min treatment with trypsin/EDTA (Life Technologies). Dislodged VECs were washed and re-plated at ~2500 cells/cm2 with irradiated 3T3-J2 feeder fibroblasts.
To examine the toxicity of H. cordata water extract on primary human VECs, cells were evaluated using the CellTiter-Blue Cell Viability Assay (Promega, Madison, WI, USA). VECs were treated with 25–200 μg/ml H. cordata water extract for 18 h. After exposure, 20 μl of CellTiter-Blue Reagent was added to each well and the cells were cultured for 2 h. Subsequently, fluorescence in each well was measured with excitation/emission at 560/590 nm. Experiments were performed in triplicate and set up in three different donors. Viability of the cells was expressed as percent of the untreated negative control group.
Stimulation of VECs by H. cordata water extract
Third passage VECs were treated with 25–200 μg/ml H. cordata water extract for 6 or 18 h. Untreated cells and cells treated with TNF-α were used as negative and positive controls, respectively. After treatment, total RNA was isolated from the cells for subsequent PCR assays, and culture supernatants were frozen at −80 °C for enzyme-linked immunosorbent assay (ELISA) and Luminex assay. Experiments were set up in three different donors; each experiment was performed in duplicate.
RNA isolation, cDNA preparation and quantitative real-time reverse transcription PCR
Total RNA was isolated from VECs with the RNeasy Mini Kit and purified of contaminating DNA using RNase-free DNase (QIAGEN, Valencia, CA, USA). 1 μg of total RNA was reverse transcribed to complementary DNA (cDNA) using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Quantitative real-time PCR was conducted using TaqMan Gene Expression Master Mix (Life Technologies) according to the manufacturer’s directions. The primers and probes for hBD2 and SLPI were as follows: hBD2 forward primer: 5′-TCCTGGTGAAGCTCCCA-3′; hBD2 reverse primer: 5′-CGCCTATACCACCAAAAACAC-3′; hBD2 probe: 5′-/56-FAM/AGGAGATAC/ZEN/AAGACCCTCATGGCTGA/3IABkFQ/-3′; SLPI forward primer: 5′-CAAGCGTGACTTGAAGTGTTG-3′; SLPI reverse primer: 5′-GAAAGGACCTGGACCACAC-3′; SLPI probe: 5′-/56-FAM/CCCTGTGAA/ZEN/AGCTTGATTCCTGCCA/3IABkFQ/-3′. Primers and probes for the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were ordered from Life Technologies. Amplification conditions were initial denaturation at 96 °C for 15 min followed by 40 cycles of denaturation at 95 °C for 15 s and annealing/extension at 60 °C for 60 s. Amplification of each sample was performed in duplicate and normalized to the housekeeping gene. The relative expression was calculated by Pfaffl’s method  and expressed as the relative fold change of the untreated control group.
ELISA and Luminex assay
Culture supernatants (collected as described above) were evaluated for secreted hBD2 and SLPI protein by ELISA (hBD2, Alpha Diagnostic, San Antonio, TX, USA; SLPI, R&D Systems, Minneapolis, MN, USA). The levels of interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, CC chemokine ligand (CCL) 2, CCL5, Interferon-gamma (IFN-γ), and TNF-α were measured by Magnetic Luminex Performance Assay (R&D Systems) according to the manufacturer’s instructions. Standard curves were generated in every set of experiments.
Statistics were calculated with SPSS Statistics. One-way analysis of variance (ANOVA) and/or Kruskal-Wallis test was applied for analysis of differences between untreated cells and cells treated with H. cordata. P-values less than 0.05 were considered to indicate significantly different outcomes.
Cytotoxicity of H. cordata water extract on primary VECs
To test for cytotoxicity, primary VECs were treated with 25–200 μg/ml of H. cordata water extract for 18 h. After treatment, cell viability was measured by the CellTiter-Blue assay. VEC viability after treatment with H. cordata water extract was close to 100 % compared to untreated control cells (Fig. 1).
Effect of H. cordata water extract on hBD2 and SLPI
Primary VECs were treated with 25–200 μg/ml of H. cordata water extract for 18 h. By using quantitative real-time reverse transcription PCR, the expression of hBD2 mRNA in VECs was found to be significantly increased by 2.37 fold after treatment with 100 μg/ml H. cordata (p < 0.05) compared to untreated cells (Fig. 2a). The expression of hBD2 mRNA after treatment with 50 or 200 μg/ml H. cordata was also increased, but not statistically significant (Fig. 2a). The expression of SLPI mRNA in VECs was significantly induced up to 1.53 fold after treatment with 25, 100, or 200 μg/ml H. cordata water extract (P < 0.05; Fig. 2b). SLPI mRNA was also increased with 50 μg/ml H. cordata but not statistically significant (Fig. 2b).
At the level of protein secretion, hBD2 was significantly increased from 3.1 pg/ml to 5.5 pg/ml after treatment with 50 μg/ml H. cordata water extract (P < 0.05) compared to untreated controls (Fig. 2c). The secretion of hBD2 by VECs after treatment with 25, 100 or 200 μg/ml H. cordata water extract was also increased, but not statistically significant (Fig. 2c). In contrast, the levels of secreted SLPI protein remained unchanged after treatment with low doses of H. cordata, and were slightly decreased with higher doses of the extract (Fig. 2d).
We also measured the expression of hBD2 and SLPI mRNA in VECs after being treated shortly with H. cordata water extract for up to 6 h. Unlike the case of 18 h treatment, 6 h of exposure with the extract had only slight effects on hBD2 or SLPI mRNA expression in VECs (Fig. 2e, f).
Cytokine and chemokine secretion by VECs in the presence of H. cordata
Next, we measured the secretion of cytokines and chemokines in the cell culture supernatants after the cells were treated with 50, 100 or 200 μg/ml of H. cordata water extract for 18 h using Luminex assay. We found that the levels of secreted IL-2 in VEC culture supernatants were significantly higher (1.2-1.4 pg/ml) than untreated control cells (0.4 pg/ml) after treatment with 50 or 200, but not 100, μg/ml H. cordata water extract (P < 0.05; Fig. 3a). Similarly, the levels of secreted IL-6 were significantly increased (from 9.4 pg/ml to 15–23 pg/ml) after the cells were treated with 100 or 200 μg/ml H. cordata water extract (P < 0.05; Fig. 3b). However, levels of IL-4, IL-8, CCL2, and TNF-α were not statistically significant differences in the presence of the extract compared to untreated control cells (Fig. 3c, d, e, f). In contrast, the level of CCL5 was decreased from a basal level of 172 pg/ml to 88–114 pg/ml at the concentrations tested (P < 0.05; Fig. 3g). The levels of secreted IL-1β, IL-10, and IFN-γ proteins were also measured, however, they were at undetectable levels.
This study demonstrated that vaginal innate immune mediators are modulated by H. cordata water extract at the concentration up to 200 μg/ml without cytotoxicity. Increased hBD2 and SLPI gene expression, as well as hBD2, IL-2 and IL-6 protein secretion were found after the cells were treated with the extract for 18 h. In contrast, decreased CCL5 protein secretion by primary human VECs was noted.
Epithelial cells lining vagina provide the first line of defense against pathogenic microorganisms in the female genital tract. The cells play an active role both in physical and chemical barriers, including the production of antimicrobial peptides [1, 2, 6]. Our findings on the effects of H. cordata on modulating the innate immune mediators produced by VECs are consistent with that of a previous study by Luo et al. (2008), which reported that H. cordata can induce the expression of hBD2 in pulmonary epithelial cells .
Several studies revealed that hBD2 is an important antimicrobial peptide, because it is expressed in epithelial cells in response to microbial compounds, microbes and cytokines [18–21] and can inhibit several pathogenic bacteria , and Candida species . Interestingly, it can inhibit HIV-1 transmission by directly inactivating HIV-1 virions, down-modulating HIV-1 co-receptor CXCR4, and inhibiting HIV replication [7, 15]. Thus, the induced expression of hBD2 by H. cordata water extract may be a useful feature of an anti-HIV microbicide or an antimicrobial agent for sexually transmitted diseases of the female reproductive tract.
Although the present study demonstrated that hBD2 was induced by the extract, it is not known whether the induction of antimicrobial peptides by the extract is sufficient to prevent or inhibit infection at the vaginal mucosa. Therefore, further study should be performed using functional assays to examine if the changes in antimicrobial peptide levels induced by the extract could prevent the proliferation of pathogens such as HIV and C. albicans. In addition, topical effects of the extract should be further explored in vivo.
SLPI is constitutively produced by several cell types including VECs [4, 36] and can also be induced by inflammatory mediators . We found that the water extract of H. cordata increased the expression of SLPI mRNA by VECs after treatment for 18 h. However, the secretion of SLPI protein was not found to be increased. This discrepancy may be due to a stimulation time that was not suitable to detect SLPI protein secretion. It may also due to degradation of SLPI in VEC culture media as a recent study reported that the secreted protein level of SLPI did not reflect mRNA expression, suggesting rapid degradation of SLPI protein in the culture supernatant . Further studies should be performed to determine the expression of SLPI in VECs after longer incubation of H. cordata to measure the level of SLPI in the late time point and to investigate the intracellular level of SLPI protein in VECs by a western blot.
Mucosal epithelial cells secrete cytokines and chemokines in response to microorganisms and other cytokines [5, 12]. Here, we demonstrated that the water extract of H. cordata increased the secretion of cytokines IL-2 and IL-6 by VECs. Although IL-2 is mainly produced by T lymphocytes, it can also be secreted at low levels by epithelial cells . IL-6 is produced by different epithelia, including VECs [5, 12]. These cytokines play important roles in the host immune responses in both innate and adaptive immunity. IL-2 mediates the proliferation and activation of T cells and also activates natural killer cells and B-cells . A previous study reported that highly active antiretroviral therapy combined with IL-2 can provide beneficial effects in the treatment of early HIV-1 infection . IL-6 is a multifunctional cytokine with both pro-inflammatory and immunoregulatory functions [12, 13, 40]. It mediates the differentiation of B-cells and enhances immunoglobulin secretion [12, 13]. Moreover, IL-6 shows anti-inflammatory activity by inhibiting IL-1 and TNF . On the other hand, IL-6 also has pro-inflammatory activity which may lead to undesirable effects such as inflammation. Further studies should be performed to elucidate if H. cordata extract might impose any adversary effects on the vaginal immunity. Of interest, previous studies demonstrated that IL-6 can inhibit HIV-1 replication in macrophages and plays a protective role in host immune responses against infections with various pathogens such as Escherichia coli, Chlamydia trachomatis, and C. albicans [41–44]. Thus, further studies should be carried out to explore whether cytokine alterations in VECs caused by H. cordata extract have functional effects, and whether the shift of cytokine profile in the culture supernatants can modify lymphocyte function and proliferation.
In addition to induction of IL-2 and IL-6, the water extract of H. cordata reduced the levels of CCL5 in the supernatants while the levels of IL-4 and TNF-α did not change. CCL5/RANTES has been identified as the HIV-suppressive factor , however, the decreased level of CCL5 after treatment with H. cordata may interrupt the effect of H. cordata in vaginal innate immunity regarding HIV-1 inhibition. Hence, the effect of H. cordata on HIV-1 inhibition in the target cells should be investigated in the future.
A recent study reported that the polysaccharide HCP-2 isolated from H. cordata water extract induced the secretion of IL-1β, TNF-α, and CCL5/RANTES by human peripheral blood mononuclear cells . The production of IL-1β, IL-6, and TNF-α by mouse peritoneal macrophages was also enhanced by H. cordata . Moreover, the production of IL-2 and IL-10 by mouse splenic lymphocytes was increased after treatment with H. cordata, whereas the level of IFN-γ decreased and the level of IL-4 remained unchanged . These divergent results are likely due to varying methodological conditions, for example, tissue model, cell type, time of treatment, and dose of the extract.
The crude extract of H. cordata used in this study contains various substances. It is therefore unclear whether the observed modulation of immune mediators was caused by a single component or several. Thus, purification of different components of the crude extract of H. cordata should be done in the future. In addition, further studies should be performed to determine whether combinations of those active ingredients would be useful in the modulation of different immune mediators.
It has been shown that H. cordata possesses antimicrobial activities against several pathogenic microbes including Staphylococcus aureus and E. coli , however, the effects of H. cordata on the vaginal normal flora such as Lactobacilli are still not known and should also be determined.
Our study indicates that H. cordata water extract induces the expression of antimicrobial peptides hBD2 and SLPI as well as the secretion of cytokines IL-2 and IL-6 by VECs and reduces the secretion of CCL5. These immune mediators have a significant role in innate and adaptive immune responses. These findings suggest that H. cordata extracts may be a useful immunomodulatory addition to vaginal microbicides and should be further investigated.
CC chemokine ligand
Enzyme-linked immunosorbent assay
Human β-defensin 2
- H. cordata :
Houttuynia cordata Thunb
Human immunodeficiency virus type 1
Secretory leukocyte protease inhibitor
Tumor necrosis factor-alpha
Vaginal epithelial cells
Cole AM. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol. 2006;306:199–230.
Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol. 2011;65:196–211.
Kresina TF, Mathieson B. Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the national institutes of health. J Infect Dis. 1999;179 Suppl 3:S392–6.
Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod. 1999;60:508–14.
Steele C, Fidel Jr PL. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002;70:577–83.
Wira CR, Grant-Tschudy KS, Crane-Godreau MA. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol. 2005;53:65–76.
Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS. 2003;17:F39–48.
Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res. 2005;84:445–50.
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human beta-defensins. Cell Mol Life Sci. 2006;63:1294–313.
McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood. 1997;90:1141–9.
Wiedow O, Harder J, Bartels J, Streit V, Christophers E. Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun. 1998;248:904–9.
Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 1995;3:266–70.
Borish LC, Steinke JW. 2 Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460–75.
Doumas S, Kolokotronis A, Stefanopoulos P. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun. 2005;73:1271–4.
Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol. 2005;79:14318–29.
Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, et al. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med. 2004;200:1337–46.
Shimoya K, Zhang Q, Temma K, Kimura T, Tsujie T, Tsutsui T, et al. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women. Maturitas. 2006;54:141–8.
Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M, et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect. 2005;7:1117–27.
Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol. 2000;22:714–21.
Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun. 2000;68:2907–15.
Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol. 2008;151:528–35.
Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol. 1994;11:733–41.
Fu J, Dai L, Lin Z, Lu H. Houttuynia cordata Thunb: a review of phytochemistry and pharmacology and quality control. Chin Med. 2013;4:101–23.
Hayashi K, Kamiya M, Hayashi T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Planta Med. 1995;61:237–41.
Chiang LC, Chang JS, Chen CC, Ng LT, Lin CC. Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med. 2003;31:355–62.
Lu H, Wu X, Liang Y, Zhang J. Variation in chemical composition and antibacterial activities of essential oils from two species of Houttuynia THUNB. Chem Pharm Bull (Tokyo). 2006;54:936–40.
Li GZ, Chai OH, Lee MS, Han EH, Kim HT, Song CH. Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation. Biol Pharm Bull. 2005;28:1864–8.
Lu HM, Liang YZ, Yi LZ, Wu XJ. Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol. 2006;104:245–9.
Chen YY, Liu JF, Chen CM, Chao PY, Chang TJ. A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo). 2003;49:327–33.
Tang YJ, Yang JS, Lin CF, Shyu WC, Tsuzuki M, Lu CC, et al. Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells. Oncol Rep. 2009;22:1051–6.
Lai KC, Chiu YJ, Tang YJ, Lin KL, Chiang JH, Jiang YL, et al. Houttuynia cordata Thunb extract inhibits cell growth and induces apoptosis in human primary colorectal cancer cells. Anticancer Res. 2010;30:3549–56.
Chapman S, Liu X, Meyers C, Schlegel R, McBride AA. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest. 2010;120:2619–26.
Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol. 2012;180:599–607.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
Luo L, Dong BR, Teng LH. Houttuynia cordata induces expression of human beta-defensin-2 mRNA in pulmonary epithelial cells in vitro. Zhong Xi Yi Jie He Xue Bao. 2008;6:716–9.
Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clin Sci (Lond). 2006;110:21–35.
Yin L, Swanson B, An J, Hacker BM, Silverman GA, Dale BA, et al. Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2. J Oral Microbiol. 2010;2:5070–81.
Aoki Y, Qiu D, Uyei A, Kao PN. Human airway epithelial cells express interleukin-2 in vitro. Am J Physiol. 1997;272:L276–86.
Martinez-Marino B, Ashlock BM, Shiboski S, Hecht FM, Levy JA. Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection. J Clin Immunol. 2004;24:135–44.
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–88.
Rogez-Kreuz C, Maneglier B, Martin M, Dereuddre-Bosquet N, Martal J, Dormont D, et al. Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int Immunol. 2005;17:1047–57.
Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun. 1996;64:3231–5.
Williams DM, Grubbs BG, Darville T, Kelly K, Rank RG. A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect Immun. 1998;66:4564–7.
Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, Puccetti P, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med. 1996;183:1345–55.
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811–5.
Cheng BH, Chan JY, Chan BC, Lin HQ, Han XQ, Zhou X, et al. Structural characterization and immunomodulatory effect of a polysaccharide HCP-2 from Houttuynia cordata. Carbohydr Polym. 2014;103:244–9.
Kim J, Park CS, Lim Y, Kim HS. Paeonia japonica, Houttuynia cordata, and Aster scaber water extracts induce nitric oxide and cytokine production by lipopolysaccharide-activated macrophages. J Med Food. 2009;12:365–73.
Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, Ho HM, et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008;118:79–85.
This study was supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0287/2552). We would like to thank Lamar Ballweber and Kimberly S. Smythe in the laboratory of Dr. M. Juliana McElrath at the Fred-Hutchinson Cancer Research Center in Seattle for technical assistance, Sean M. Hughes at the University of Washington for editorial assistance, Dr. Cary A. Moody from the Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, for providing the 3T3-J2 fibroblast feeder cell line; and Dr. Allison A. McBride from the Laboratory of Viral Diseases at the National Institute of Allergy and Infectious Diseases for advice regarding the culture of primary vaginal epithelial cells.
The authors declare that they have no competing interests.
SS developed proposal, performed experiments, analyzed data, prepared and revised manuscript. FH advised experiments and revised manuscript. AP performed experiments. WN designed study, developed proposal, applied for research grant, directed project, interpreted results, prepared and revised manuscript. All authors read and approved the final manuscript.